Philip Morris’s fourth quarter results were driven by strong growth in its smoke-free portfolio, with management emphasizing double-digit volume gains for its IQOS, ZYN, and VIVE products across multiple regions. CEO Jacek Olczak called attention to the accelerated adoption of smoke-free alternatives, stating, “Our leading global position in smoke-free products enables us to deliver a fifth consecutive year of positive volumes.” Growth was broad-based, including notable gains in Europe, rapid expansion in new markets like Taiwan, and resilience in combustibles despite normalized industry declines and specific supply chain disruptions, particularly in Turkey.
Tobacco company Philip Morris International (NYSE:PM) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $10.36 billion. Its non-GAAP profit of $1.70 per share was in line with analysts’ consensus estimates.
As of February 6, 2026, Philip Morris International (NYSE: PM) stands at a historic crossroads. Long regarded as the quintessential "Big Tobacco" play, the company has spent the last decade aggressively cannibalizing its own legacy combustible business to lead a global "smoke-free" revolution. Today, the results of this gamble are no longer speculative; they are [...]
Tobacco company Philip Morris International (NYSE:PM) met Wall Streets revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $10.36 billion. Its non-GAAP profit of $1.70 per share was in line with analysts’ consensus estimates.
